Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH)

Typically moves ±8.58% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-08-14 ESTIMATED
search

Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH) has reported earnings 18 times since Aug 16, 2021. The stock moves an average of ±8.58% the day after reporting, closing higher 50.0% of the time. Its largest post-earnings gain was +15.9% (Aug 14, 2025) and its largest decline was -35.63% (Mar 31, 2025). The next earnings report is predicted for 2026-08-14 (estimated).

Earnings reactions

How RVPH moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

18

Avg Abs. Movement

±8.58%

Positive %

50.0%

Negative %

50.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 13, 2026 ☽ POST +0% open_in_new
Mar 30, 2026 ☀ PRE -10.58% open_in_new
Nov 13, 2025 ☽ POST -7.41% open_in_new
Aug 14, 2025 ☽ POST +15.9% open_in_new
event

Earnings Count

18

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.58%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

Recent SEC Filings

6 most recent
Form Date Filed View on EDGAR
25-NSE 20260710 open_in_new SEC.gov
SCHEDULE 13G/A 20260515 open_in_new SEC.gov
SCHEDULE 13G 20260514 open_in_new SEC.gov
10-Q 20260513 open_in_new SEC.gov
8-K 20260513 open_in_new SEC.gov
8-K 20260513 open_in_new SEC.gov

Frequently asked about RVPH earnings

When does Reviva Pharmaceuticals Holdings, Inc. Common Stock report earnings next? expand_more

Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH)'s next earnings date is estimated for 2026-08-14. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does RVPH stock move after earnings? expand_more

Over 18 reports, RVPH has moved an average of ±8.58% the session after earnings, closing higher 50.0% of the time.

What was RVPH's biggest post-earnings move? expand_more

RVPH's largest post-earnings gain on record was +15.9% on Aug 14, 2025, and its largest decline was -35.63% on Mar 31, 2025.

Where can I find Reviva Pharmaceuticals Holdings, Inc. Common Stock's SEC filings? expand_more

All of Reviva Pharmaceuticals Holdings, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers